The Effect Of Duloxetine Dose Escalation and Tapering on the Incidence of Adverse Events (AE) in Women with Stress Urinary Incontinence (SUI)

Bump R1, Yalcin I1, Voss S 1 1. Lilly Research Laboratories

Abstract Category

Pharmacology: Clinical

Abstract 116
Clinical Pharmacology:Chaired by Martin Michel and Lynn Stothers
Scientific Podium Poster Session 15
Friday 2nd September 2005
14:52 - 15:00
Links

Abstract

29/03/2024 13:58:48